Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 15, 2022

GnRHa Use During Chemotherapy in Premenopausal Early Breast Cancer Patients Does Not Negatively Impact Long-Term Outcomes

Journal of the National Cancer Institute

 

Additional Info

Journal of the National Cancer Institute
Long-Term Outcomes with Pharmacological Ovarian Suppression during Chemotherapy in Premenopausal Early Breast Cancer Patients
J. Natl. Cancer Inst 2021 Nov 25;[EPub Ahead of Print], M Lambertini, L Boni, A Michelotti, E Magnolfi, AA Cogoni, AM Mosconi, M Giordano, O Garrone, G Arpino, F Poggio, P Cinacchi, C Bighin, P Fregatti, P Pronzato, E Blondeaux, L Del Mastro

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading